The Start-up Garage application form will be available January 14, 2011.

Our new application form will be ready January 14, 2011. In the meantime, if you are a post secondary student in Ottawa, OTTN encourages you take some time over the winter holidays to think about your business, or idea for a business in order to secure $18,000 and a spot in the Start-up Garage to build your company. In particular, think about your product or service, your customer, and what you can do over the summer with the cash and resources to make your business a reality.

Spartan RX Gets CE Mark for UOHI test

Spartan Bioscience Announces CE Marking for First Point-of-Care DNA Personalized Medicine Testing System

The CE Mark allows the Spartan RX CYP2C19 to be distributed in select countries across Europe, Middle East, Africa, Latin America, and Asia Pacific. The Spartan RX CYP2C19 designed to help cardiologists determine most effective anti-blood clotting drug and dosage at the onset of heart attacks.

Launched in August 2010, Spartan RX CYP2C19, was designed to help cardiologists identify patients who have a gene mutation that causes impaired metabolism to the popular anti-blood clotting medication Plavix® (clopidogrel), which may lead to major adverse cardiac events. The CYP2C19*2 mutation is found in up to 30% of the population. Individuals with this mutation who receive the standard dose of Plavix following a cardiac stent insertion to open clogged arteries have an 11.7% absolute risk of death, stroke, or heart attack in the first year (compared to 8.3% for non-carriers).

The U.S. Food and Drug Administration issued a warning for Plavix in March 2010. The genotype results provided by the Spartan RX CYP2C19 test will help determine the most effective anti-blood clotting drug and dosage at the onset of heart attacks.

“Currently, genetic testing for Plavix non-response is performed in central labs and it takes one to seven days to get a test result back. This is often too late because most of the complications for CYP2C19*2 carriers occur in the first 24 to 48 hours,” said Derek So, M.D., staff cardiologist, University of Ottawa Heart Institute. “As a one-hour point-of-care test, the Spartan RX CYP2C19 has the potential to significantly reduce major cardiac events in heart attack patients.”

“The long-term trend for DNA testing is to move from the central lab to point-of-care,” said Paul Lem, M.D., founder of Spartan Bioscience. “Spartan has turned this prediction into reality by creating a fully integrated DNA collection, extraction and analysis platform, and adding an intuitive interface that can be operated by nurses and other non-technical users.”

The Spartan RX System and Spartan RX CYP2C19 test are currently available for investigational testing. At the University of Ottawa Heart Institute, Dr. So is using the testing system to run the RAPID GENE study, a prospective randomized clinical trial, which will determine if alternative anti-blood clotting therapy with Effient® (prasugrel) for CYP2C19*2 carriers reduces major adverse cardiovascular events.

In October 2010, Spartan Bioscience was named as one of Canada’s Top 10™

For more information on this announcement see:
http://eon.businesswire.com/news/eon/20101220005316/en/CYP2C19/CE-Mark/Point-of-Care

uOttawa Spin-off company (BDR Technologies) named a Top Innovator by youngStartup Ventures

BDR Technologies Named a Top Innovator -Award Recognizes Cutting Edge Private Companies Driving the Future of Innovation

BIODIESEL REACTOR (BDR) TECHNOLOGIES announced today that it has been selected to present as one of 70 Top Innovators at the annual New England Venture Summit by youngStartup Ventures. The list of privately held companies recognizes those that play a leading role in innovation for the Technology, Life Sciences and Clean-tech sectors.

As one of the Top Innovators chosen, Ken Lawless, CEO of BDR Technologies, will present the company at the exclusive 2010 New England Venture Summit on December 15th at the Hilton Boston Dedham, where a select group of over 400 entrepreneurs, investors, and corporate developers will gather to be the first to meet this next wave of leading edge companies. For more information on the summit see: http://www.youngstartup.com/newengland2010/overview.php

BDR Technologies Inc. is an Ottawa-based clean energy company that provides innovative process solutions for the global biodiesel industry. BDR’s novel membrane reactor generates high quality biodiesel, exceeding industry standards (and the more stringent standards demanded by big oil), at significantly reduced capital and operating costs, without the need for costly downstream distillation of the final product. The technology was developed at the University of Ottawa and has been licensed exclusively to BDR. A four million litre per year demonstration plant is in development and is projected to be commissioned in late 2011.

uOttawa Researcher, Cognivue and NSERC Engage partnership featured on BDC site

Dr. Robert Laganiere is working with Cognivue Corporation as part of an NSERC Engage grant which links companies with technical problems with university expertise.
An excerpt from the story follows:

Robert Laganière isn’t a professional driver. But since September (2010), this computer science professor’s job description has included taking a car out for a spin. “I’m having fun making lane changes,” Laganière says with a chuckle from his office at the University of Ottawa. Laganière is working on a project that could one day prevent car accidents. It could also become an important source of revenue for a local high-tech firm, CogniVue Corporation.

With video that Laganière’s collects on his road trips, his team at U. of O.’s VIVA lab is working to improve a CogniVue algorithm. It allows a camera to detect the car’s position and sound a warning when it moves into a neighbouring lane. And that, hopefully, will lead to products that automakers are looking for.

“Driver awareness technology is our primary target market,” says Tina Jeffrey, Product Marketing Engineer at the Gatineau, Quebec’s CogniVue. This is the first time that Laganière has joined forces with CogniVue, a company that develops Image Cognition Processors and software for use in devices that require real-time image and video analytics. Their partnership is benefiting from a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).

The full story is available at http://www.bdc.ca/EN/advice_centre/articles/Pages/building_partnerships_between_business_and_universities.aspx

OTTN and OCE Launch the Start-up Garage

OTTN and the Ontario Centres of Excellence (OCE) launched the 2011 uOttawa Start-up Garage at the University of Ottawa. Over 80 people were registered for this event, representing students from diverse backgrounds such as engineering, management, and the life sciences.

The Start-up Garage provides students with an opportunity to start or grow their own business. We are looking for creative and motivated individual or teams with an interest in entrepreneurship to take advantage of this unique opportunity.

The uOttawa Start-up Garage will provide:

• $6,000 in funding per student to a maximum of $18,000 per team
• Office & meeting space
• Mentoring
• Access to business experts
• Runs June 1, 2011 – August 31, 2011

Application forms will be available from OTTN on December 15, 2010

Read more of this post